Literature DB >> 23295286

Hyperinsulinism/hyperammonemia (HI/HA) syndrome due to a mutation in the glutamate dehydrogenase gene.

Maria Lúcia Corrêa-Giannella1, Daniel Soares Freire, Ana Mercedes Cavaleiro, Maria Angela Zanella Fortes, Ricardo Rodrigues Giorgi, Maria Adelaide Albergaria Pereira.   

Abstract

The hyperinsulinism/hyperammonemia (HI/HA) syndrome is a rare autosomal dominant disease manifested by hypoglycemic symptoms triggered by fasting or high-protein meals, and by elevated serum ammonia. HI/HA is the second most common cause of hyperinsulinemic hypoglycemia of infancy, and it is caused by activating mutations in GLUD1, the gene that encodes mitochondrial enzyme glutamate dehydrogenase (GDH). Biochemical evaluation, as well as direct sequencing of exons and exon-intron boundary regions of the GLUD1 gene, were performed in a 6-year old female patient presenting fasting hypoglycemia and hyperammonemia. The patient was found to be heterozygous for one de novo missense mutation (c.1491A>G; p.Il497Met) previously reported in a Japanese patient. Treatment with diazoxide 100 mg/day promoted complete resolution of the hypoglycemic episodes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23295286     DOI: 10.1590/s0004-27302012000800004

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  2 in total

1.  Interaction of islet α-cell and β-cell in the regulation of glucose homeostasis in HI/HA syndrome patients with the GDH(H454Y) mutation.

Authors:  Guanghong Jia; James R Sowers
Journal:  Diabetes       Date:  2014-12       Impact factor: 9.461

2.  DDIEM: drug database for inborn errors of metabolism.

Authors:  Marwa Abdelhakim; Eunice McMurray; Ali Raza Syed; Senay Kafkas; Allan Anthony Kamau; Paul N Schofield; Robert Hoehndorf
Journal:  Orphanet J Rare Dis       Date:  2020-06-11       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.